D'ABUNDO, Lucilla
 Distribuzione geografica
Continente #
NA - Nord America 3.097
EU - Europa 1.666
AS - Asia 1.386
SA - Sud America 191
Continente sconosciuto - Info sul continente non disponibili 98
AF - Africa 34
OC - Oceania 3
Totale 6.475
Nazione #
US - Stati Uniti d'America 2.993
SG - Singapore 495
DE - Germania 475
CN - Cina 326
PL - Polonia 300
IT - Italia 299
FI - Finlandia 265
VN - Vietnam 169
BR - Brasile 136
HK - Hong Kong 96
BD - Bangladesh 89
GB - Regno Unito 84
UA - Ucraina 63
CA - Canada 60
TR - Turchia 45
ID - Indonesia 39
SE - Svezia 39
FR - Francia 38
JP - Giappone 32
IN - India 27
MX - Messico 27
AR - Argentina 25
RU - Federazione Russa 23
ES - Italia 16
NL - Olanda 14
CZ - Repubblica Ceca 11
IQ - Iraq 11
ZA - Sudafrica 11
LT - Lituania 9
CO - Colombia 8
AT - Austria 7
MY - Malesia 6
PK - Pakistan 6
UZ - Uzbekistan 6
EG - Egitto 5
SA - Arabia Saudita 5
VE - Venezuela 5
BO - Bolivia 4
CL - Cile 4
EC - Ecuador 4
KR - Corea 4
MA - Marocco 4
AU - Australia 3
HR - Croazia 3
JM - Giamaica 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AZ - Azerbaigian 2
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.378
Città #
Ashburn 416
Munich 409
Singapore 303
Warsaw 297
San Jose 283
Fairfield 247
Helsinki 197
Woodbridge 174
Houston 135
Beijing 128
Seattle 119
Chandler 110
Santa Clara 105
Wilmington 99
Cambridge 95
Hong Kong 91
Ferrara 78
Ann Arbor 77
New York 72
Jacksonville 71
Council Bluffs 69
Los Angeles 65
Dallas 54
Ho Chi Minh City 51
Milan 35
Jakarta 34
Tokyo 32
Hanoi 31
Nanjing 26
Shanghai 26
London 25
Turku 24
Montreal 23
Phoenix 23
Atlanta 22
Orem 22
Lauterbourg 21
Chicago 20
Izmir 20
Jyväskylä 20
Princeton 19
São Paulo 19
Rome 17
Boardman 16
Bologna 16
San Diego 15
Toronto 15
Turin 15
Denver 14
Mexico City 14
Nanchang 11
Dong Ket 10
Nuremberg 10
Buffalo 9
Manchester 9
Mountain View 9
San Francisco 9
Stockholm 9
Chennai 8
Johannesburg 8
Shenyang 8
Boston 7
Da Nang 7
Falls Church 7
Redwood City 7
Addison 6
Bremen 6
Brno 6
Haiphong 6
Hefei 6
Poplar 6
Tashkent 6
Baghdad 5
Brooklyn 5
Dearborn 5
Guangzhou 5
Hebei 5
Naples 5
Pavia 5
Salt Lake City 5
Somerville 5
Tianjin 5
Vancouver 5
Vienna 5
Washington 5
Zhengzhou 5
Ankara 4
Bari 4
Belo Horizonte 4
Cagliari 4
Changsha 4
City of London 4
Guarulhos 4
Honolulu 4
Kunming 4
Lancaster 4
Miami 4
Moscow 4
New Delhi 4
Ningbo 4
Totale 4.605
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 413
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 377
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 325
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 313
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 305
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 304
Studi pre-clinici per lo sviluppo di approcci terapeutici basati sui microRNA in un modello di Leucemia Linfatica Cronica 295
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 278
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 271
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 264
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 251
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 250
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 244
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 243
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 239
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 212
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 198
Mutated beta-catenin evades a microRNA-dependent regulatory loop 197
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 192
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 180
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 178
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells 170
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 145
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 136
P3.12.20 VAF of EGFR Mutations in Relation to Early Tumor Shrinkage or Deepness of Response During Osimertinib in NSCLC Patients 113
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells 107
null 89
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 79
null 63
The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis 44
Totale 6.475
Categoria #
all - tutte 24.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022191 0 0 23 3 10 13 10 15 6 18 25 68
2022/2023246 19 19 12 29 44 33 17 17 30 3 13 10
2023/2024238 13 21 9 5 17 48 12 48 1 9 4 51
2024/20251.393 20 17 59 37 90 186 217 144 279 91 111 142
2025/20262.351 235 52 136 276 341 159 347 124 217 230 156 78
2026/2027281 55 136 90 0 0 0 0 0 0 0 0 0
Totale 6.475